Synergy Health Plc Rating Reiterated by N+1 Singer (SYR)
Synergy Health Plc (LON:SYR)‘s stock had its “buy” rating restated by research analysts at N+1 Singer in a report released on Thursday, AnalystRatingsNetwork reports.
Synergy Health Plc (LON:SYR) opened at 1010.66 on Thursday. Synergy Health Plc has a 1-year low of GBX 891.95 and a 1-year high of GBX 1165.00. The stock’s 50-day moving average is GBX 1121. and its 200-day moving average is GBX 1092.. The company’s market cap is £591.4 million.
A number of other firms have also recently commented on SYR. Analysts at Numis Securities Ltd initiated coverage on shares of Synergy Health Plc in a research note to investors on Wednesday, August 28th. They set an “add” rating and a GBX 1,300 ($20.86) price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “sell” rating on shares of Synergy Health Plc in a research note to investors on Wednesday, July 31st. They now have a GBX 902 ($14.47) price target on the stock. Finally, analysts at Investec reiterated an “add” rating on shares of Synergy Health Plc in a research note to investors on Friday, July 26th. They now have a GBX 1,170 ($18.77) price target on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of GBX 1,118 ($17.94).
Synergy Health plc delivers a range of specialist outsourced services to healthcare providers and other customers concerned with health management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.